Synthesis and Characterisation of [90Y]-Bz-DTPA-oct: A Yttrium-90-Labelled Octreotide Analogue for Radiotherapy of Somatostatin Receptor-Positive Tumours

This publication has 25 references indexed in Scilit:

• Characterization of Somatostatin Receptor Subtypes
  Published by Wiley ,2007
• (2-[18F]fluoropropionyl-(d)phe1)-octreotide, a potential radiopharmaceutical for quantitative somatostatin receptor imaging with PET: Synthesis, radiolabeling, in vitro validation and biodistribution in mice
  Nuclear Medicine and Biology, 1994
• SDZ CO 611: a highly potent glycated analog of somatostatin with improved oral activity
  Life Sciences, 1993
• Somatostatin receptor subtype gene expression in human and rodent tumors
  Life Sciences, 1993
• The mechanism of hepatic uptake of a radiolabelled monoclonal antibody
  International Journal of Cancer, 1992
• [111In-DTPA-D-Phe1]-octreotide, a potential radiopharmaceutical for imaging of somatostatin receptor-positive tumors: synthesis, radiolabeling and in vitro validation
  Life Sciences, 1991
• Monoclonal antibodies to placental alkaline phosphatase: Preclinical evaluation in a human xenograft tumour model of F(ab')2 and Fab fragments
  International Journal of Cancer, 1988
• Synthesis of 1-(p-isothiocyanatobenzyl) derivatives of DTPA and EDTA. Antibody labeling and tumor-imaging studies
  Inorganic Chemistry, 1986
• SMS 201–995: A very potent and selective octapeptide analogue of somatostatin with prolonged action
  Life Sciences, 1982
• Hypothalamic Polypeptide That Inhibits the Secretion of Immunoreactive Pituitary Growth Hormone
  Science, 1973